Revolution Medicines
About Company
Revolution Medicines is a clinical-stage precision oncology company specializing in the development of novel targeted therapies for RAS-addicted cancers. Their research and development focuses on two key areas: RAS(ON) Inhibitors, designed to suppress various oncogenic RAS protein variants, and RAS Companion Inhibitors, intended for use in combination therapies. The company is dedicated to serving patients with cancers containing mutations in the RAS signaling pathway.
